Form 4: Tiziana Life Sciences CEO Buys Shares
Insider Transaction (Form 4)
Ivor Elrifi, Chief Executive Officer of Tiziana Life Sciences Ltd, purchased 321,423 shares of common stock on August 4, 2026.
Summary
- Open-market purchase: acquired 83,807 COMMON STOCK at $0.97 ($81,293) on August 4, 2026; holds 4,556,068 after (Indirect).
- Open-market purchase: acquired 237,616 COMMON STOCK at $1.00 ($237,616) on August 5, 2026; holds 4,793,684 after (Indirect).
Sentiment
Score: 8
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $318,909, committing personal capital to the stock.
Insider Transactions
Ivor Elrifi — Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-04 | Open-market purchase | COMMON STOCK | 83,807 | $1 | $81.3K | 4,556,068 |
| 2026-08-05 | Open-market purchase | COMMON STOCK | 237,616 | $1 | $237.6K | 4,793,684 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-04 | Open-market purchase (83,807 shares) |
| 2026-08-05 | Open-market purchase (237,616 shares) |
Keywords
insider transaction, Form 4, TLSA, Tiziana Life Sciences Ltd, bullish, Ivor Elrifi
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.